American Renal Associates Holdings Revenue, Profits - ARA Quarterly Income Statement

Add to My Stocks
$14.68 $0.08 (0.54%) ARA stock closing price Aug 15, 2017 (Closing)

Financial analysis of American Renal Associates Holdings involves more than just checking the American Renal Associates Holdings stock price, by looking at the financial statements of the company in detail. In the income statement, an investor can look at important parameters like revenue, gross profits, net profits, and EPS basic to gain deeper insights. The income statement for ARA which implies a QoQ revenue growth of $8.96M is specific to a period of time. Investors typically check YoY or QoQ revenue growth. The operating expenses (also check: American Renal Associates Holdings assets and American Renal Associates Holdings free cash flow) as shown in the American Renal Associates Holdings profit and loss statement 2017-Q2 total to $158.84M. This line item has decreased from $164.55M compared with last quarter. View details of revenue and profits for American Renal Associates Holdings for latest & last 40 quarters.

show more
View Previous Quarters
View Next Quarters
Fiscal year is Jan - Dec.2017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q42015 Q32015 Q22015 Q1
American Renal Associates Holdings Net Sales or Revenues
Cost Of Goods Sold (COGS)118.06M120.3M121.17M116.11M109.71M105.45M102.6M100.11M96.1M92.13M
American Renal Associates Holdings Gross Profit
Research & Development Expense----------
Selling General & Admin Expense31.4M35.18M43.86M37.4M33.86M21.52M20.58M21.47M20.08M17.2M
Income Before Depreciation Depletion Amortization36.54M21.54M34.1M39.43M41.98M45.15M51.04M46.35M45.31M39.99M
Depreciation Depletion Amortization9.38M9.07M9.26M8.68M8.25M7.67M9M7.67M7.43M7.74M
Non Operating Income-3.17M4.51M-3.44M12.56M-12.54M-----
Interest Expense7.19M7.6M7.37M7.37M8.94M12.25M10.77M11.81M11.36M11.46M
American Renal Associates Holdings Pretax Income
Provision for Income Taxes0.41M-3.52M-2.17M-0.1M-1.14M2.66M3.57M3.27M3.33M2.2M
Minority Interest18.5M14.15M23.69M23.62M22.48M18.8M20.89M19.49M18.15M15.7M
Investment Gains Losses----------
Other Income----------
Income Before Extraordinaries & Disc Operations16.39M-12.33M-7.12M12.42M-9.09M3.76M27.72M4.11M5.02M2.88M
Extraordinary Items & Discontinued Operations----------
American Renal Associates Holdings Net Income (Profit/Loss)
Average Shares used to compute Diluted EPS30.98M30.91M30.89M31.44M28.41M22.79M-22.77M22.66M22.61M
Average Shares used to compute Basic EPS30.98M30.91M30.89M30.87M28.41M22.21M-22.17M22.13M22.11M
Income Before Nonrecurring Items5.55M1.87M8.74M9.35M8.3M3.76M-4.11M5.02M2.88M
Income from Nonrecurring Items-10.19M-14.2M-15.86M3.07M-17.39M-----
American Renal Associates Holdings Earnings Per Share Basic Net
American Renal Associates Holdings Earnings Per Share Diluted Net
EPS Diluted Before Nonrecurring Items0.
Preferred Dividends Acc Pd----------
Dividends Common----------
Dividend Per Share Common----------
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters
Get Income statement for another ticker

American Renal Associates Holdings stock analysis involves checking at least a few of the important things like:
  • Revenue: The money received by selling of goods or services comes under this line item. A QoQ growth (See: American Renal Associates Holdings revenue chart) implies that the company is growing, which has been the case with American Renal Associates Holdings. One must stay away from stocks whose revenues are declining.
  • Bottom line: The word bottom line comes because it is usually the last line of the income statement and refers to the actual profits after deducting all expenses from the revenues. ARA stock had a healthy bottom line growth.
The income statement is also called the profit and loss statement. Apart from the income statement, one can check the American Renal Associates Holdings historical stock prices to check how the price has moved with time. .

American Renal Associates Holdings Income Statement - Key Financial Ratios

PS ratio (
price sales ratio
Operating margin
Net profit margin
Dividend yield